Clinical Trials · NCT07437586
Topical GHK-Cu Gel for Acute Skin Wound Healing
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Hudson Biotech
- Enrollment
- 60
- Start date
- Feb 2026
- Locations
- 1 site, China
- Primary endpoint
- Time to complete re-epithelialization (days) of each wound, defined as 100% epithelial coverage without drainage, confirmed by blinded clinical assessment and standardized photography.